共 29 条
- [27] Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2023, 35 (06): : 263 - 271
- [29] LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) TARGET GOAL ACHIEVEMENT RATE ACCORDING TO PHYSICIANS' COMPLIANCE TO ESTABLISHED CLINICAL GUIDELINES FROM NATIONAL CHOLESTEROL EDUCATION PROGRAM-ADULT TREATMENT PANEL (NCEP-ATP) AND AMERICAN COLLEGE OF CARDIOLOGY/AMERICAN HEART ASSOCIATION (ACC/AHA): RESULTS FROM KOREA CRISTAR STUDY VALUE IN HEALTH, 2017, 20 (09) : A619 - A620